Alphyn Biologics Reports Encouraging Interim Results of Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection

Topical treatment is achieving all endpoints for efficacy and safety in mild, moderate, and severe atopic dermatitis.

The skin microbiome: challenges and opportunities in developing probiotics

Amine Zorgani (Microbiome Mavericks) talks about the importance of the skin microbiome in maintaining skin health and the need for continued research in this field.

Microbiota transplant after gastric bypass improves metabolism in mice

The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.

Nestlé partners with APC Microbiome Ireland

The collaboration will focus on various aspects of the human microbiome that could benefit new product development.

A cross-sectional study on the link between gut microbiota and inflammation in bipolar depression

Depressed BD patients present significant alterations in the taxonomic compositions of their gut microbiota, and this may be related to inflammatory pathways and depression severity.

Probiotic sanitation as a sustainable tool for IPC and AMR control

Elisabetta Caselli, University of Ferrara (Italy), talks about a new and innovative use of probiotics to modulate the "hospital microbiome” in order to reduce the use of chemical disinfectants.

IPC 2023: probiotic business framework overview

George Paraskevakos, Executive Director at International Probiotics Association, talks about probiotic and live biotherapeutic products market evolution and perspective.

How infections alter the population of a gut microbe

The findings of a recent study suggest that a mild gastrointestinal infection can alter gut commensal populations in ways that boost the commensal’s ability to proliferate during an infection.

A new mechanism in rheumatoid arthritis aggravation: Fusobacterium Nucleatum-mediated release of FadA-containing outer membrane vesicles

The findings of a recent study imply that Fusobacterium nucleatum may play a causal role in worsening RA, offering potential therapeutic targets for effectively alleviating RA symptoms.

IPC 2023 and the postbiotics session: the gathering of the different parties 

The highlights of the Postbiotics Discussion Panel that took place in Bratislava during IPC 2023.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top